Bead Enhancement of EV Analysis
暂无分享,去创建一个
Cesar M. Castro | Hakho Lee | R. Weissleder | Hsing-Ying Lin | B. Wolpin | H. Im | Caleigh Curley | M. Welch | Katherine S. Yang
[1] Hakho Lee,et al. Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy , 2017, Science Translational Medicine.
[2] Jennifer C. Jones,et al. Labeling Extracellular Vesicles for Nanoscale Flow Cytometry , 2017, Scientific Reports.
[3] S. Hanash,et al. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer , 2017, Journal of the National Cancer Institute.
[4] Mackenzie A. Eagleson,et al. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review , 2017, The American Journal of Gastroenterology.
[5] Yan Li,et al. Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples for Diagnosis and Treatment Monitoring , 2017, Nature Biomedical Engineering.
[6] Jennifer C. Jones,et al. Flow Cytometric Analysis of Extracellular Vesicles. , 2017, Methods in molecular biology.
[7] J. Lötvall,et al. A rapid, automated surface protein profiling of single circulating exosomes in human blood , 2016, Scientific Reports.
[8] L. Bujanda,et al. Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have. , 2016, Annals of translational medicine.
[9] J. García-Foncillas,et al. Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis? , 2016, BioMed research international.
[10] Christian Pilarsky,et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.
[11] M. Büchler,et al. Combined evaluation of a panel of protein and miRNA serum‐exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity , 2015, International journal of cancer.
[12] Bob S. Carter,et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma , 2015, Nature Communications.
[13] K. R. Jakobsen,et al. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma , 2015, Journal of extracellular vesicles.
[14] I. Sargent,et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing , 2014, Journal of thrombosis and haemostasis : JTH.
[15] K. Kinzler,et al. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. , 2014, Cancer research.
[16] Hakho Lee,et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor , 2014, Nature Biotechnology.
[17] Hakho Lee,et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy , 2012, Nature Medicine.
[18] S. Batra,et al. Early diagnosis of pancreatic cancer: challenges and new developments. , 2012, Biomarkers in medicine.
[19] A. Guha,et al. Extracellular vesicles – vehicles that spread cancer genes , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[20] Ciro Tetta,et al. Exosome/microvesicle-mediated epigenetic reprogramming of cells. , 2011, American journal of cancer research.
[21] Bin Zhang. CD73: a novel target for cancer immunotherapy. , 2010, Cancer research.
[22] Y. Goto,et al. Smoking and serum CA19‐9 levels according to Lewis and secretor genotypes , 2008, International Journal of Cancer.
[23] M. Gönen,et al. Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma , 2008, Annals of Surgical Oncology.
[24] Shenmin Zhang,et al. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer , 2007, Molecular Cancer Therapeutics.
[25] J. K. Lee,et al. Clinical usefulness of carbohydrate antigen 19‐9 as a screening test for pancreatic cancer in an asymptomatic population , 2004, Journal of gastroenterology and hepatology.
[26] Laurence Zitvogel,et al. Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.
[27] J. Cameron,et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.